Guggenheim Maintains Buy on Gentex, Raises Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Ronald Jewsikow has maintained a Buy rating on Gentex (NASDAQ:GNTX) and increased the price target from $38 to $40.

March 19, 2024 | 11:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guggenheim analyst Ronald Jewsikow has reaffirmed a Buy rating on Gentex and raised the price target from $38 to $40.
The increase in price target by a reputable analyst like Ronald Jewsikow suggests a positive outlook on Gentex's stock, likely due to strong company fundamentals or market position. This endorsement could lead to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100